Martin Mackay - Net Worth and Insider Trading
Martin Mackay Net Worth
The estimated net worth of Martin Mackay is at least $10 Million dollars as of 2024-11-13. Martin Mackay is the EVP & Global Head of R&D of Alexion Pharmaceuticals Inc and owns about 50,688 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $9 Million. Martin Mackay is also the CEO of Rallybio Corp and owns about 719,126 shares of Rallybio Corp (RLYB) stock worth over $801,825. Details can be seen in Martin Mackay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martin Mackay has not made any transactions after 2022-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Martin Mackay
Martin Mackay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin Mackay owns 5 companies in total, including 5:01 Acquisition Corp (FVAM) , Charles River Laboratories International Inc (CRL) , and Alexion Pharmaceuticals Inc (ALXN) among others .
Click here to see the complete history of Martin Mackay’s form 4 insider trades.
Insider Ownership Summary of Martin Mackay
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FVAM | 5:01 Acquisition Corp | 2020-10-13 | director |
| CRL | Charles River Laboratories International Inc | 2017-07-01 | director |
| ALXN | Alexion Pharmaceuticals Inc | 2017-03-01 | EVP & Global Head of R&D |
 | | 2007-10-04 | Senior Vice President |
| | 2022-01-11 | director & Chief Executive Officer |
Martin Mackay Latest Holdings Summary
Martin Mackay currently owns a total of 2 stocks. Among these stocks, Martin Mackay owns 50,688 shares of Alexion Pharmaceuticals Inc (ALXN) as of March 1, 2017, with a value of $9 Million and a weighting of 92.02%. Martin Mackay also owns 719,126 shares of Rallybio Corp (RLYB) as of January 11, 2022, with a value of $801,825 and a weighting of 7.98%.
Latest Holdings of Martin Mackay
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2017-03-01 | 50,688 | 182.50 | 9,250,560 |
| RLYB | Rallybio Corp | 2022-01-11 | 719,126 | 1.12 | 801,825 |
Holding Weightings of Martin Mackay
Martin Mackay Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin Mackay has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 1,855 shares on March 1, 2017, which brought Martin Mackay around $244,174.
According to the SEC Form 4 filings, Martin Mackay has made a total of 1 transactions in Rallybio Corp (RLYB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rallybio Corp is the acquisition of 10,000 shares on January 11, 2022, which cost Martin Mackay around $103,500.
Insider Trading History of Martin Mackay
- 1
Martin Mackay Trading Performance
GuruFocus tracks the stock performance after each of Martin Mackay's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin Mackay is -24%. GuruFocus also compares Martin Mackay's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin Mackay within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martin Mackay's insider trading performs compared to the benchmark.
Performance of Martin Mackay
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 29.1 | | | | | |
| Relative Return to S&P 500(%) | 35.35 | | | | | |
Martin Mackay Ownership Network
Ownership Network List of Martin Mackay
Ownership Network Relation of Martin Mackay
Martin Mackay Owned Company Details
What does 5:01 Acquisition Corp do?
Who are the key executives at 5:01 Acquisition Corp?
Martin Mackay is the director of 5:01 Acquisition Corp. Other key executives at 5:01 Acquisition Corp include director & 10 percent owner & Co-CEO Andrew J. Schwab , director & 10 percent owner & Co-CEO Kush Parmar , and 10 percent owner 5am Ventures Vi, L.p. .
5:01 Acquisition Corp (FVAM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of 5:01 Acquisition Corp (FVAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of 5:01 Acquisition Corp (FVAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
5:01 Acquisition Corp (FVAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
5:01 Acquisition Corp Insider Transactions
Martin Mackay Mailing Address
Above is the net worth, insider trading, and ownership report for Martin Mackay. You might contact Martin Mackay via mailing address: Pfizer Inc Attn Corporate Secretary, 235 East 42nd Street, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
